For those who have failed to recognise the true colours of the global institutions charged with acting for world peace, health and human rights, it will surely come as a shock to realise that such international bodies are part of the problem and not the solution.
They are complicit in the carefully planned entanglement agenda which obscures truth, strings out discussion and evades taking action, while presenting themselves as ‘the caring face of global welfare’.
These bodies are agents of the elite globalist push for ‘A New World Order’, top down power now going for full spectrum dominance.
Heading this list must be The United Nations, followed closely by The World Health Organisation and the World Economic Forum. These three institutions are in fact, inseparably joined at the hip.
There are many more such groupings, of course, but it’s beyond the scope of this article to go into their part in the power game.
It is deeply shocking to witness the UN’s CEO, Antonio Guterres, issuing pleas for a sustained humanitarian break in the Israeli army’s mass murder of men, women and children in Gaza, while simultaneously enforcing the elite cabal’s monstrous Agenda 2030 Sustainable Development programme for a ‘Net Zero’ techno-globalist take over of humanity.
It must be remembered that this is the organisation that backed the Agenda 21 ‘sustainability’ programme which was tied into the 1992 Rio Earth Summit, placing a centralised industrial scale ‘Fake Green Agenda’ at the centre of efforts to disenfranchise the world’s true human scale food producers, energy providers and health practitioners.
A plan specifically geared to put corporate banking institutions in charge of globalising this false green agenda – while casting aside the true wisdom and experience of independent, benign, artisan and local/regional manufacturing and farming enterprises that form the only equitable base for a creative and diverse national and international economy.
All this is, of course, intimately bound up with the dissemination of ‘Global Warming’ scare stories via the manipulated and entirely deficient UN International Panel on Climate Change (IPCC) computer modelling exercises designed to ‘prove’ anthropogenic CO2 to be the ‘Mr Evil of industrial output’.
The UN is funded by nation states and by private ‘elite’ personalities like Bill Gates, determined to exert and maintain their power base within the top-of-the-pyramid status quo.
Given its historical standing, is the UN likely to genuinely push for a permanent cease fire and establishment of a peace keeping force to block the wholesale slaughter of the innocence in Gaza?
Guterres, Schwab (WEF) and Ghebreyesus (WHO) are puppets of the shadow government responsible for fomenting wars, famine and planetary depopulation, all under the guise of offering benign interventions in conflicts they themselves are party to setting in motion.
The Great Reset is the latest name given to this particular phase in the establishment of the long promised totalitarian New World Order.
Ghebreyesus, at the WHO, overseas the ‘health genocide’ side of things. He is hoping to pull-off the great post Covid ‘Emergency Health Treaty’ this May (May 2024), whereby every country in the world is expected to offer itself up in compliance to whatever commands are issued by this latest model of health dictatorship. A substantial gift for Big Pharma and for depopulation fanatics.
‘Rule by dictatorship’ is also heavily promoted by Klaus Schwab at the WEF, a man/organisation completely devoid of sympathy for the human race, but of key significance to the A.I.techno industrial push for a transhuman take over of life on earth.
Further feeble proclamations of intent to save innocent lives in Gaza come from global heads of state, of course. With one wary eye on public opinion and the other on the vindictive power of the Zionist lobby, they attempt to steer a ‘middle path’ which will not unduly upset either side.
Witnessing such duplicity coming from individuals supposed to act with wisdom and responsibility at moments of intense human crisis, is deeply unnerving.
Cowardice barely describes the weak, apologetic vacillations that such individuals spew forth in front of expectant TV cameras and hobbled journalists supplying ‘breaking’ stories for mass media outlets.
The obsession to ‘protect one’s interests’ over making any commitment to finding genuine solutions to urgent crises has become the only instinct left functioning in these sad representatives of modern day ‘political diplomacy’.
A remarkably stark example of this disease was on display amongst Britain’s political milieu in February. Sir Keith Starmer, head of the British Labour Party, was apparently ‘shocked’ when one of his MP’s standing for re-election in local elections – was on the record (recorded) saying that the October 7th Hamas uprising was allowed to happen by Netanyahu as a pretext for preserving his power base and genociding the Palestinian population of Gaza.
Starmer, terrified of the British Zionist lobby accusing his party of being antisemitic, made the unfortunate MP apologise profusely for his ‘terrible error’ and then informed him that he would be ‘deselected’ as a candidate at the forthcoming elections.
So that’s it – anyone falling for the egregious political error of speaking the truth, is immediately consigned to the doghouse. There to become a useful victim of the blame passing exercise designed to save the reputations of such effigies of political vacuity as Sir Keith Starmer.
He is no exception, the political class is schooled in the art of self preservation; mostly through seamless lying and the blatant evasion of duty.
It is abundantly clear that the ruling elite/shadow government regards all human life as simply ‘collateral’ and useful only in so far as it serves their cause of achieving ‘full spectrum dominance’.
It is equally clear – and many degrees more tragic – that billions of planetary citizens accept such behaviour as ‘the new normal’ for world governance, thereby spectacularly failing in their duty to call it out.
It is at this level that we who are aware each have a crucial role to play in preventing our already traumatized world descending further into the abyss.
What role might this be? I hear some asking.
It is quite simply to hold the line of humane decency, moral courage and a determination to act as guardians of the health and welfare of humanity as a whole. And this must always also mean ‘the planet’. Humanity and the planet are inseparable from one another.
We are charged, whether as generals or foot soldiers, with the defence and preservation of that which was gifted to us by the Supreme.
Extraordinary people are doing extraordinary things to save lives in the midst of this pandemic of mindless cruelty. They are the true heroes of the hour. Every one of us has it in us to join that highly esteemed band of courageous souls.
Everyone of us who will now step forward to engage in the pact-less struggle to overcome the agents of darkness, will be enriched beyond measure for taking such a bold stand – and will be held in the highest esteem along with those already engaged.
Those who don’t want to stand defiant in the face of the present calculated destruction of life’s most precious values, will suffer the fate of never knowing what it means to be alive.
Julian Rose is an organic farmer, writer, broadcaster and international activist. He is author of four books of which the latest ‘Overcoming the Robotic Mind’ is a clarion call to resist the despotic New World Order takeover of our lives. Do visit his website for further information www.julianrose.info
Overcoming the Robotic Mind – Why Humanity Must Come Through
Pennsylvania’s Erie GOP Senator Dan Laughlin is initiating a measure to change the gun ownership laws, enabling medical cannabis users to possess firearms. Laughlin argues that Second Amendment rights shouldn’t be violated because medical marijuana is a legitimate treatment for symptoms. Laughlin notes that the amendment is aimed at defending constitutional rights and personal liberty.
However, changing state laws will not be enough because federal law forbids marijuana users from owning firearms. The senator, who is surprised by the federal government’s passivity, takes inspiration from a case filed by the district attorney of Warren County against federal limits.
Robert Greene, the district attorney for Warren County and a certified medical marijuana patient in Pennsylvania, filed a lawsuit against the government about the prohibition of gun ownership by cannabis consumers.
Pennsylvania Family Institute President Michael Geer opposes Laughlin’s effort, citing possible risks associated with combining marijuana and firearms. Without recommended amounts, he claims, users run the risk of misuse, especially when using high-THC cannabis products.
Nevertheless, Laughlin, who humorously acknowledges his role as a leading advocate for marijuana legalization within the GOP, remains undeterred. Last year, Laughlin wrote to Pennsylvania’s acting police commissioner, asking him to review a federal decision that declared the federal prohibition on cannabis users owning firearms to be unlawful.
The senator’s advocacy for medical marijuana patients’ gun rights comes as state officials contemplate the legalization of recreational cannabis. Recently, Governor Josh Shapiro’s budget proposal called on legislators to move forward with legalizing cannabis for recreational use, emphasizing the need to stay up-to-date with surrounding states.
There is a growing interest in legalizing recreational cannabis in both chambers, with Laughlin leading the legalization reforms in the senate. The House of Representatives, which is now controlled by Democrats, has had several hearings on the issue. A recent poll reveals substantial public support for recreational cannabis legalization in Pennsylvania, with approximately two-thirds of voters endorsing the policy change.
Meanwhile, federal and state laws that prohibit drug users from purchasing firearms have presented challenges for authorities and Second Amendment supporters as more jurisdictions legalize cannabis. Notably, federal law stipulates that it is illegal to purchase or carry a firearm if one uses cannabis or any other restricted narcotic.
However, the act that gave rise to that ban has recently been contested in several courts, with some ruling that the restriction is unconstitutional.
The DOJ has staunchly supported the policy, arguing that people who use cannabis present distinct risks to society that warrant denying them their Second Amendment rights.
This bill is likely to be of interest to many cannabis companies such as SNDL Inc. (NASDAQ: SNDL) as its outcome could set a precedent that many other jurisdictions with medical marijuana markets may try to emulate.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
Germany recently passed a recreational marijuana legislation that decriminalizes marijuana, provides a foundation for cultivation social clubs and permits home growing. Under the legislation, cultivation social clubs are defined as not-for-profit organizations that allow members to obtain cannabis for recreational use.
The law, which hasn’t yet been read in the Bundesrat, will be enacted on April 1, 2024. The Bundesrat isn’t required to provide “consent” and will focus more on looking into the measure itself. However, if it does summon the Mediation Committee, then the measure may not go into effect in April as is expected.
Bloomwell Group’s CEO and cofounder, Niklas Kouparanis, stated in a recent interview that Germany was welcoming a new era of progressive policy when it came to drugs. He also noted that some suppliers would be allowed to sell material and equipment to the social clubs, as well as rent facilities and property for the clubs.
Despite this move forward, however, the legislation has been called a quasi-legislation because it maintains general prohibition on recreational cannabis with exceptions. Konstantin Grubwinkler, an attorney at Reubel Grubwinkler Rechtsanwälte, stated that while marijuana possession will remain illegal under the new law, individuals will still be able to:
Cultivate up to three plants at home
Possess no more than 50 grams of marijuana at home and 25 grams in public
Additionally, social club members will be entitled to 50 grams of marijuana per month from the facilities, with adults also being permitted to grow marijuana in the clubs together. Grubwinkler also noted that the law did not cover the sale of marijuana.
The legislation approved by the central legislative body last week was a diluted version of the initial bill. Originally, the country had intended to fully legalize marijuana. However, resistance from the European Commission led legislators to a two-pillar approach.
It is expected that the first marijuana clubs will launch in the summer. The clubs will be controlled by strict rules that focus on location, membership and mode of operation. For instance, the new law stipulates that members of a social club may be supported in the growing process by workers who earn roughly $581 a month. This is because the government wants growing and processing duties to be shared collectively among club members, which will total about $500 a club.
Membership fees are also expected to counterbalance the cost of production because clubs will not be permitted to sell marijuana to nonmembers. Additionally, clubs will be permitted to hire workers for tasks that aren’t associated with cultivation, such as law or accounting.
The international marijuana community, including companies such as like Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), will be watching to see what actual form the implementation of this proposed law takes and how it could shape marijuana policy in the European Union bloc.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
(CNW) Edmonton — Aurora Cannabis Inc., the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescription platform in the UK.
Designed to support UK patients on their journey of well-being, the Script Assist platform provides access to high quality medication through their portal. Script Assist will make available an extensive range of medical cannabis products from Aurora’s leading portfolio of products. Starting in March three newly launched, high-quality hang-dried and hand-processed flower products from Aurora’s EU GMP facilities in Canada will also become available on www.scriptassist.co.uk: Pedanios 26/1 EHD-CA (Cultivar: Electric Honey Dew) and Pedanios 28/1 CMK-CA (Cultivar: Chemango Kush) with a high THC content, as well as Pedanios 10/10 EQI-CA (Cultivar: Equiposa) with balanced THC/CBD content.
“Together with our new partner, we are committed to further improve the UK medical cannabis landscape by providing patients with access to premium, high-quality products through Script Assist’s innovative technology solution,” said Trisha Cassidy, managing director, Aurora UK & Ireland. “We believe it is necessary and critical to expand not only access to products, but also provide valuable information to guide patients through their medical cannabis journey. We are proud to be a trusted partner for their health,” said Cassidy.
Within the platform, Script Assist is launching ‘Find a Doctor’, an easy-to-use app, which seamlessly connects patients with specialist prescribing doctors. The full range of Aurora’s medical cannabis products will be available for patients through prescription by all private doctors and clinics using the platform, transforming the UK medical cannabis prescription journey.
(Globe Newswire) Vancouver — EnWave Corporation has signed a new royalty-bearing commercial license with an established South American food manufacturer that currently sells health supplements, snacks, cereals, baked goods, among other products.
The Royalty Partner also signed an equipment lease agreement to lease two 10kW Radiant Energy Vacuum (REV®) dehydration machines, enabling immediate commercial production for the products developed in collaboration with EnWave. The Royalty Partner will have the option to buy both 10kW REV® units within six months at a pre-agreed price.
Concurrent with signing the lease agreement and as a condition to keep the commercial license, the Royalty Partner is finalizing financing to procure a 120kW REV® machine, which must be completed within six months.
(Globe Newswire) New York and Neumünster, Germany — Tilray Brands, Inc., a global leader in cannabis research, cultivation, production, and distribution, today provides an update on Germany’s milestone cannabis legalization and what it means for the future of cannabis in Europe and for Tilray.
As a global leader in the legalized medical and adult-use cannabis markets and a market leader in medical cannabis across Europe, with a leading market share in Germany, Tilray is bullish on the positive paradigm shift that the new German drug policy creates for the future of cannabis in Europe.
Irwin D. Simon, Tilray Brands’ chairman and CEO, stated, “We see tremendous growth opportunities stemming from Germany’s landmark cannabis policy update. The new German medical market opportunity equates to about $3bn while the European opportunity, could represent a powerful growth market consisting of a potential $45bn medical market alone. Our presence in Europe allows Tilray to grow our brands globally from a base of over 700 million people in Europe, which is twice the population of the U.S.”
The public perception regarding the new cannabis reforms in Germany is mainly centered around cultivation for personal use and the establishment of cannabis social clubs. However, what is of greater importance for Tilray are the new opportunities, which flow from the new German Medical Cannabis Act. One fundamental change is the removal of cannabis from the list of prohibited substances in the Narcotics Act. This de-scheduling change is expected to significantly expand the medicinal cannabis market in Germany as it would allow for more doctors to prescribe medical cannabis more easily to patients and not only as a medication of last resort, which will allow for greater accessibility to patients and potentially allow for broader health insurance coverage.
Advertisement
Further, the German Medical Cannabis Act provides for the abolishment of the tender process for in-country cultivation of medicinal cannabis and replaces it with a licensing scheme. Today, only a small portion of the medical cannabis serving German patients is produced in Germany and what may be cultivated is set forth in the tender. As the operator of one of only three in-country cultivation facilities located in Germany today, these legislative changes would allow Tilray to better meet patient needs by expanding its medical cannabis product offerings, which in turn would significantly increase Tilray’s cannabis production in Germany by approximately 5x and more than double its revenue opportunity. Tilray also owns and operates Tilray Pharma, an established medical distribution platform in Germany that distributes traditional branded and generic pharmaceutical medicines and medical cannabis across 13,000 pharmacies as well as wholesalers and distributors.
We also believe that these landmark reforms in Germany could have an impact on cannabis drug policy across Europe as other countries may adopt Germany’s approach. We believe this could lead to significant growth for Tilray in Europe where we already have a very meaningful presence, and where Tilray continues to seek to strengthen its leadership position and grow market share in over 20 countries including Portugal, Poland, Italy, the UK, and the Czech Republic.
Canada’s cannabis excise duty on fresh flower, plants, and seeds, in which producers pay the higher of $1 per gram or 10% of a gram’s value, is viewed by most industry players as unsustainable.
This was brought home in September 2023 in a Cannabis Council of Canada (C3) survey in which 96% of respondents viewed the current model as excessively punitive.
However, as drumbeats for duty reform grow louder—with the federal House of Commons Standing Committee on Finance recently recommending a switch to a 10% ad valorem rate—little attention has been paid to the actual processes required to bring relief.
The challenges, say experts, fall into two domains: the first is purely practical, involving the legal requirements and logistical challenges; and the second is more political, given that the federal government shares 75% of the revenue with the provinces and territories (with the exception of Manitoba).
Practical considerations
The federal excise duty framework falls under the purview of the Minister of Finance. The requirements are clear.
“Changes to the federal component of the excise duty rates require amendments to the Excise Act, 2001,” Caroline Feggans, a spokesperson with the Department of Finance, told StratCann via email. “Under the coordinated agreements, any changes to the federal component of the excise duty rates would trigger corresponding changes to the additional duty component in respect of a participating province or territory.”
This would ensure that the revenue split between the federal government and the provinces and territories remains constant. Notably, from a purely legal perspective, it appears that the federal government can act unilaterally. It doesn’t require anyone’s permission.
The process for amending legislation would depend on the specifics of the Bill and attendant political considerations, with varying amounts of consultation. Within the government itself, multiple stakeholders would be involved.
“Any change would start with a policy review led by Health Canada, with key input on excise tax from the Department of Finance, and oversight by the Prime Minister’s Office and the Privy Council Office,” says Denis Gertler, a former government regulator. “Changes are then operationalized through the Canada Revenue Agency (CRA). The CRA would also be consulted about policy changes, but mainly from an operationalizing perspective.”
Recently, Innovation, Science and Economic Development (ISED) announced a consultation with industry representatives, perhaps to give cannabis businesses a stronger voice.
“I think it’s too soon to say what the outcome of this exercise will be,” says Gertler.
The politics of change
The provinces would also have to be engaged—one of the biggest hurdles. The provinces are receiving the lion’s share of the money, which flows directly into general revenue, and that’s hard to give up.
“This is definitely more complicated politically than it is legally,” says Trina Fraser, a partner at Brazeau Seller Law in Ottawa who has questioned the validity of the excise duty.
“The coordinated tax agreements contain typical contract language, including that the contract can only be amended in writing with the mutual consent of the parties,” she says. “But, there is a provision in the agreements which states that if the federal government changes the federal component of excise duty, which it can unilaterally do, then the provincial component shall be automatically amended as well to maintain proportionality.”
However, Fraser says it is unlikely that the feds would use this power to unilaterally overhaul the excise rates due to political reasons. In effect, the unilateral federal power, while legal, may be politically untenable.
“Changing the rate structure on flower to a fixed 10% model, as the federal House of Commons Standing Committee on Finance has recommended, would affect the provinces, and is something they probably wouldn’t do without provincial consent,” she says. “Yes, it would simplify reporting, but it would reduce the duty collected, so would likely, practically speaking, require provincial buy-in.”
That said, there are permutations that could be viable.
“Things like a national stamp, a digital stamp, changing the timing of remittances, or having the provincial distributors remit the duty, are all examples of changes that would assist producers (from an operational expense, administrative burden and/or cash flow perspective) but wouldn’t require any change to the rate structure,” she says.
“In my opinion, the public health community will have a greater impact on the Panel’s final recommendation,” says Gertler. “The thrust of legalization is not how to build a dynamic cannabis industry, but is more concerned with protecting young persons from the harms of cannabis consumption.”
Nonetheless, the industry has been speaking with one voice for some time about the negative effects of the excise duty. This may be hard to ignore, given that some producers are now paying over 30% in excise duty.
“I do expect there to be a recommendation for a reduction,” says Brad Poulos, a professor of entrepreneurship at Toronto Metropolitan University. “However, I’m loathe to predict how the federal government reacts.”
A reality check
Given that the cannabis industry’s efforts to be treated as an industry with legitimate economic concerns have been consistently drowned out by larger societal considerations, a strategic pivot may be in order.
“The cannabis industry seems to not be fully cognizant of all the political forces at play regarding the excise tax,” says Gertler. “To advocate for more industry-positive changes, it needs to find common cause with some of these groups and come to the feds together. Harm reduction advocates could be approached, as well as the research community. There may be others, too.”
A prime example, says Gertler, would be to make the case that a stronger, responsible legal industry is vital to beating the illegal market, which sells directly to youth with no regulation. Otherwise, the concerns of the cannabis industry, and by association excise duty, are simply not top of mind.
“I’m not sure that the federal government cares if smaller LPs go out of business,” says Gertler, “unless that would result in some seat losses in the next election, which I think is unlikely.”
There is also the simple economic message that it makes more sense for the government to take a smaller part of a bigger, growing pie than to kill an industry by gouging it. This approach also helps to grow the legal market and to address health and policing concerns related to the unregulated market.
“There are still a lot of people buying from the illicit market,” says Fraser. “Reducing tax could be a key component in the legal market getting more market share.”
In effect, a simplified and coordinated approach to excise tax reform could kill a few birds with one stone: helping grow the legal market, thus driving more tax revenue, while making it less lucrative for those in the unregulated space.
Then, says Boutros from Metropolitan University, the government can get back in the game: “Once the illicit industry has been reduced much more than it is, the government can look at getting greedy with taxes.”
Recent Comments